RIPK1 and amyotrophic lateral sclerosis: Moreover, serum RIPK1 levels in patients with ALS are correlated with the severity of bulbar symptoms, as indicated by higher serum RIPK1 levels in patients with more severe bulbar symptoms (Fig. 4d).